Increased plasma levels of soluble HLA-G (sHLA-G) have been reported in CLL patients compared to healthy donors [99,100], even though no significant correlation was found with known CLL prognosticators. This evidence concerns the gene HLA-G and B-cell chronic lymphocytic leukemia.